The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway-Reference-Cited by-同舟云学术

The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway

Published:2017-10-04 Issue:1 Volume:36 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

He Shanyang,Niu Gang,Shang Jianhong,Deng Yalan,Wan Zhiyong,Zhang Cai,You Zeshan,Shen Hongwei

Funder

the Guangdong Natural Science Foundation, China

National Natural Scientific Foundation of China

the Science and Technology Planning Project of Guangzhou City, China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-017-0607-0.pdf

Reference38 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

2. Chang SJ, Bristow RE. Surgical technique of en bloc pelvic resection for advanced ovarian cancer. J Gynecol Oncol. 2015;26(2):155.

3. Wright JD, Chen L, Tergas AI, Patankar S, Burke WM, Hou JY, Neugut AI, Ananth CV, Hershman DL. Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol. 2015;125(6):1345–52.

4. Menon U, Jacobs IJ. Ovarian cancer screening in the general population: current status. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2001;11(Suppl 1):3–6.

5. Kumar A, Bakkum-Gamez JN, Weaver AL, McGree ME, Cliby WA. Impact of obesity on surgical and oncologic outcomes in ovarian cancer. Gynecol Oncol. 2014;135(1):19–24.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNF149 confers cisplatin resistance in esophageal squamous cell carcinoma via destabilization of PHLPP2 and activating PI3K/AKT signalling;Medical Oncology;2023-09-02

2. RNF149 confers cisplatin resistance in esophageal squamous cell carcinoma via destabilization of PHLPP2 and activating PI3K/AKT signalling;2023-06-28

3. Inverse Impact of Cancer Drugs on Circular and Linear RNAs in Breast Cancer Cell Lines;Non-Coding RNA;2023-05-19

4. Overexpression of tripartite motif-containing 47 (TRIM47) confers sensitivity to PARP inhibition via ubiquitylation of BRCA1 in triple negative breast cancer cells;Oncogenesis;2023-03-11

5. P-Element-Induced Wimpy Testis Proteins and P-Element-Induced Wimpy Testis-Interacting RNAs Expression in Ovarian Cancer Stem Cells;Genetic Testing and Molecular Biomarkers;2023-02-01